- We are working hard to come back as soon as possible.
- Nous travaillons dur pour revenir au plus vite.
- Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
- Estamos trabajando duro para volver lo antes posible.
- Stiamo lavorando sodo per tornare il prima possibile.
- Wij werken hard om zo snel mogelijk weer terug te zijn.
- We are working hard to come back as soon as possible.
- Nous travaillons dur pour revenir au plus vite.
- Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
- Estamos trabajando duro para volver lo antes posible.
- Stiamo lavorando sodo per tornare il prima possibile.
- Wij werken hard om zo snel mogelijk weer terug te zijn.
Profil
Alan Tyndall is the founder of Magenta Therapeutics, Inc. (2015).
He is currently a Professor-Emeritus at the University of Basel (since 1991) and serves as Secretary at the World Scleroderma Foundation.
Mr. Tyndall received his undergraduate degree from the University of Sydney in 1972.
Mr. Tyndall is also the founder of Iterata AG.
Postes actifs de Alan Tyndall
| Sociétés | Poste | Début |
|---|---|---|
| University of Basel | Corporate Officer/Principal | 01/01/1991 |
| World Scleroderma Foundation | Secrétaire Général | - |
| Iterata AG | Fondateur | - |
Anciens postes connus de Alan Tyndall
| Sociétés | Poste | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Fondateur | - |
Formation de Alan Tyndall
| The University of Sydney | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
| World Scleroderma Foundation | |
| Iterata AG |